First-in-human study of an investigational injection
This trial tests a new injection for the first time in healthy volunteers to see how safe it is and how the body handles it. It may help determine if the drug is suitable for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are generally healthy, with no major medical conditions.
- Your weight is at least 50 kg (men) or 45 kg (women), and your BMI is between 18 and 26.
- If you are a woman who can become pregnant, you must have a negative pregnancy test before dosing.
- You have no history of cancer, autoimmune diseases, or organ transplants.
- You have not had a recent infection or vaccination in the last 4 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called ISH0613 in healthy volunteers to see if it is safe and how the body processes it. It is the first time this drug is given to humans.
This is a first-in-human study of a new injected medication that may help with certain conditions. The trial is looking for healthy volunteers to check the drug's safety and how it works in the body.
This study tests a new injection called HEC-151 in healthy men to see how it affects the body at different single doses. It's one of the first steps to see if the drug is safe and could one day help people with diabetes or related conditions.
This early-phase study tests a new injectable drug (JY1001) in healthy volunteers to see how safe it is and how the body handles it. It's a first step in finding out if the drug could help people with certain conditions in the future.
This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
Hear when a new Healthy Subjects (HS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.